BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 37515699)

  • 21. Inhibition of tumor cell growth by monoterpenes in vitro: evidence of a Ras-independent mechanism of action.
    Karlson J; Borg-Karlson AK; Unelius R; Shoshan MC; Wilking N; Ringborg U; Linder S
    Anticancer Drugs; 1996 Jun; 7(4):422-9. PubMed ID: 8826611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Betulinic acid shows anticancer activity against equine melanoma cells and permeates isolated equine skin in vitro.
    Weber LA; Meißner J; Delarocque J; Kalbitz J; Feige K; Kietzmann M; Michaelis A; Paschke R; Michael J; Pratscher B; Cavalleri JV
    BMC Vet Res; 2020 Feb; 16(1):44. PubMed ID: 32024502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol.
    Ariazi EA; Satomi Y; Ellis MJ; Haag JD; Shi W; Sattler CA; Gould MN
    Cancer Res; 1999 Apr; 59(8):1917-28. PubMed ID: 10213501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural Compounds in the Chemoprevention of Malignant Melanoma.
    Danciu C; Soica C; Antal D; Alexa E; Pavel IZ; Ghiulai R; Ardelean F; Babuta RM; Popescu A; Dehelean CA
    Anticancer Agents Med Chem; 2018; 18(5):631-644. PubMed ID: 29173184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Examination of different factors influencing the vascularization of human cutaneous melanoma].
    Kiss J
    Magy Onkol; 2008 Dec; 52(4):385-9. PubMed ID: 19068467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limonene and Perillyl Alcohol Derivatives: Synthesis and Anticancer Activity.
    da Silva CEH; Gosmann G; de Andrade SF
    Mini Rev Med Chem; 2021; 21(14):1813-1829. PubMed ID: 33583370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review on liposome-based therapeutic approaches against malignant melanoma.
    Mirzavi F; Barati M; Soleimani A; Vakili-Ghartavol R; Jaafari MR; Soukhtanloo M
    Int J Pharm; 2021 Apr; 599():120413. PubMed ID: 33667562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of programmed cell death in Trypanosoma cruzi by Lippia alba essential oils and their major and synergistic terpenes (citral, limonene and caryophyllene oxide).
    Moreno ÉM; Leal SM; Stashenko EE; García LT
    BMC Complement Altern Med; 2018 Jul; 18(1):225. PubMed ID: 30053848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin cancer, including related pathways and therapy and the role of luteolin derivatives as potential therapeutics.
    Juszczak AM; Wöelfle U; Končić MZ; Tomczyk M
    Med Res Rev; 2022 Jul; 42(4):1423-1462. PubMed ID: 35187675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of tumor progression by naturally occurring terpenoids.
    Kuttan G; Pratheeshkumar P; Manu KA; Kuttan R
    Pharm Biol; 2011 Oct; 49(10):995-1007. PubMed ID: 21936626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticancer activity of seaweeds.
    Gutiérrez-Rodríguez AG; Juárez-Portilla C; Olivares-Bañuelos T; Zepeda RC
    Drug Discov Today; 2018 Feb; 23(2):434-447. PubMed ID: 29107095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines.
    Bardon S; Picard K; Martel P
    Nutr Cancer; 1998; 32(1):1-7. PubMed ID: 9824849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chitosan nanoparticles containing limonene and limonene-rich essential oils: potential phytotherapy agents for the treatment of melanoma and breast cancers.
    Alipanah H; Farjam M; Zarenezhad E; Roozitalab G; Osanloo M
    BMC Complement Med Ther; 2021 Jul; 21(1):186. PubMed ID: 34215240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of apoptosis induced by anticancer compounds in melanoma cells.
    Gartel AL
    Curr Top Med Chem; 2012; 12(1):50-2. PubMed ID: 22280162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interferons and malignant melanoma].
    Dreno B
    Rev Med Interne; 2002 Nov; 23 Suppl 4():489s-493s. PubMed ID: 12481404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation.
    Crowell PL; Ren Z; Lin S; Vedejs E; Gould MN
    Biochem Pharmacol; 1994 Apr; 47(8):1405-15. PubMed ID: 8185648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoterpene biotransformation by Colletotrichum species.
    Sales A; Afonso LF; Americo JA; de Freitas Rebelo M; Pastore GM; Bicas JL
    Biotechnol Lett; 2018 Mar; 40(3):561-567. PubMed ID: 29288353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valproic acid induces apoptosis, p16INK4A upregulation and sensitization to chemotherapy in human melanoma cells.
    Valentini A; Gravina P; Federici G; Bernardini S
    Cancer Biol Ther; 2007 Feb; 6(2):185-91. PubMed ID: 17218782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol.
    Gelb MH; Tamanoi F; Yokoyama K; Ghomashchi F; Esson K; Gould MN
    Cancer Lett; 1995 May; 91(2):169-75. PubMed ID: 7767906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Histone Deacetylases in Malignant Melanoma: A Future Therapeutic Agent or Just Great Expectations?
    Garmpis N; Damaskos C; Garmpi A; Dimitroulis D; Spartalis E; Margonis GA; Schizas D; Deskou I; Doula C; Magkouti E; Andreatos N; Antoniou EA; Nonni A; Kontzoglou K; Mantas D
    Anticancer Res; 2017 Oct; 37(10):5355-5362. PubMed ID: 28982843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.